{"id":"https://openalex.org/W2356579930","doi":null,"title":"Clinical Study of Iressa in the Treatment of 45 Patients with Advanced NSCLC","display_name":"Clinical Study of Iressa in the Treatment of 45 Patients with Advanced NSCLC","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2356579930","mag":"2356579930"},"language":"en","primary_location":{"id":"mag:2356579930","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-YXLL201111005.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764373577","display_name":"The Journal of Medical Theory and Practice","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4360969194","host_organization_name":"Hebei Preventive Medicine Association","host_organization_lineage":["https://openalex.org/P4360969194"],"host_organization_lineage_names":["Hebei Preventive Medicine Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The Journal of Medical Theory and Practice","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113905573","display_name":"Zhu Jin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Zhu Jin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5113905573"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.9929999709129333},{"id":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer","display_name":"advanced non-small cell lung cancer","score":0.9599999785423279},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.9419999718666077},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.7919999957084656},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.7509999871253967},{"id":"https://openalex.org/keywords/skin-rash","display_name":"rash","score":0.8220000267028809},{"id":"https://openalex.org/keywords/interstitial-lung-disease","display_name":"interstitial lung disease","score":0.9279999732971191},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.5440000295639038},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9683132767677307},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.8284995555877686},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7210384011268616},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.6706143617630005},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6610581874847412},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.586453914642334},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5596275329589844},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5356075167655945},{"id":"https://openalex.org/C2779802037","wikidata":"https://www.wikidata.org/wiki/Q40878","display_name":"Diarrhea","level":2,"score":0.5119653940200806},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5116551518440247},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.48030585050582886},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4581931531429291},{"id":"https://openalex.org/C2777543607","wikidata":"https://www.wikidata.org/wiki/Q1153419","display_name":"Interstitial lung disease","level":3,"score":0.4368240237236023},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.24995073676109314},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2365119457244873},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2356579930","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-YXLL201111005.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764373577","display_name":"The Journal of Medical Theory and Practice","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4360969194","host_organization_name":"Hebei Preventive Medicine Association","host_organization_lineage":["https://openalex.org/P4360969194"],"host_organization_lineage_names":["Hebei Preventive Medicine Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The Journal of Medical Theory and Practice","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2373913328","https://openalex.org/W2359218101","https://openalex.org/W2354727825","https://openalex.org/W2082118762","https://openalex.org/W2377924237","https://openalex.org/W2369059710","https://openalex.org/W2372621195","https://openalex.org/W2384614119","https://openalex.org/W2382505700","https://openalex.org/W2370338097"],"abstract_inverted_index":{"Objective:To":[0],"study":[1],"the":[2,27,88],"efficacy":[3],"and":[4,67,76,80,85,97,112],"toxicity":[5],"of":[6,9,74],"Gefitinib(Iressa)in":[7],"treatment":[8],"advanced":[10,22,91],"Non-small":[11],"Cell":[12],"Lung":[13],"Cancer.Methods:From":[14],"October":[15],"2006":[16],"to":[17,51],"Augest":[18],"2010,45":[19],"patients":[20,89,108],"with":[21,90,104],"NSCLC":[23],"received":[24],"Iressa":[25],"until":[26],"disease":[28,44],"progression":[29],"or":[30],"intolerable":[31],"toxic":[32,106],"reaction.Results:2":[33],"cases":[34],"were":[35,65,72],"CR":[36],"among":[37],"all":[38],"patients,the":[39],"response":[40],"rate":[41,46,64],"was":[42,47,54,60],"33.33%,the":[43],"control":[45],"77.78%,the":[48],"median":[49,57],"time":[50,59],"tumor":[52],"progression(TTP)":[53],"9.5":[55],"months,the":[56],"survival":[58,63,99],"8.5":[61],"months.One-year,two-year":[62],"46.60%":[66],"32.50%":[68],"respectively.The":[69],"main":[70],"toxicities":[71],"rash,itch":[73],"skin,diarrhea,nausea":[75],"vomitting,mouth":[77],"catarrh,hepatic":[78],"dysfunction":[79],"interstitial":[81],"pneumonia.Conclusion:Iressa":[82],"is":[83,101],"effective":[84],"tolerable":[86],"for":[87],"NSCLC.It":[92],"can":[93],"remarkably":[94],"improve":[95],"symptom":[96],"prolong":[98],"time.It":[100],"well":[102,110],"tolerated":[103],"minimal":[105],"reaction.All":[107],"have":[109],"compliance":[111],"tolerability.":[113]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}